Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Disc Medicine Inc (IRON)

Disc Medicine Inc (IRON)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,859,361
  • Shares Outstanding, K 29,726
  • Annual Sales, $ 0 K
  • Annual Income, $ -76,430 K
  • EBIT $ -125 M
  • EBITDA $ -125 M
  • 60-Month Beta 0.60
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 3.78

Options Overview Details

View History
  • Implied Volatility 57.58% ( +0.09%)
  • Historical Volatility 80.63%
  • IV Percentile 1%
  • IV Rank 1.63%
  • IV High 207.09% on 03/26/24
  • IV Low 55.11% on 05/10/24
  • Put/Call Vol Ratio 0.14
  • Today's Volume 58
  • Volume Avg (30-Day) 86
  • Put/Call OI Ratio 0.65
  • Today's Open Interest 915
  • Open Int (30-Day) 901

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 12 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate -1.05
  • Number of Estimates 8
  • High Estimate -0.88
  • Low Estimate -1.41
  • Prior Year -0.97
  • Growth Rate Est. (year over year) -8.25%

Price Performance

See More
Period Period Low Period High Performance
1-Month
44.81 +41.72%
on 10/31/24
68.73 -7.60%
on 11/11/24
+12.74 (+25.08%)
since 10/21/24
3-Month
44.69 +42.10%
on 09/23/24
68.73 -7.60%
on 11/11/24
+14.19 (+28.79%)
since 08/21/24
52-Week
25.60 +148.07%
on 04/01/24
77.60 -18.16%
on 03/04/24
+11.76 (+22.71%)
since 11/21/23

Most Recent Stories

More News
Disc Medicine to Participate in Upcoming Investor Conferences

IRON : 63.51 (+1.53%)
Disc Medicine Reports Third Quarter 2024 Financial Results and Provides Business Update

IRON : 63.51 (+1.53%)
Disc Medicine Secures $200 Million in Non-Dilutive Debt Financing from Hercules Capital, Inc.

IRON : 63.51 (+1.53%)
Disc Medicine Announces Multiple Presentations Across Portfolio at the 66th American Society of Hematology (ASH) Annual Meeting

IRON : 63.51 (+1.53%)
Disc Medicine Announces Successful End of Phase 2 Meeting with FDA for Bitopertin in Erythropoietic Protoporphyria (EPP), Including Potential for Accelerated Approval

IRON : 63.51 (+1.53%)
Disc Medicine to Host Conference Call on End of Phase 2 FDA Meeting for Bitopertin in Erythropoietic Protoporphyria (EPP)

IRON : 63.51 (+1.53%)
Disc Medicine Presents Positive Data from SAD Cohorts of a Phase 1b Trial in Patients with Chronic Kidney Disease (CKD) and Anemia at the 2024 American Society of Nephrology (ASN) Kidney Week

IRON : 63.51 (+1.53%)
Disc Medicine Appoints Seasoned Industry Executive Rahul Kaushik, Ph.D. as Chief Technical Officer

IRON : 63.51 (+1.53%)
Disc Medicine Announces Presentation of New Data from Phase 1b Trial of DISC-0974 in Patients with Chronic Kidney Disease (CKD) and Anemia at 2024 American Society of Nephrology (ASN) Kidney Week

IRON : 63.51 (+1.53%)
Stocks Close Mixed as US Manufacturing Strength Dampens Rate Cut Optimism

The S&P 500 Index ($SPX ) (SPY ) Monday closed down -0.20%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.60%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.21%. Stock indexes...

$SPX : 5,948.71 (+0.53%)
SPY : 593.67 (+0.54%)
$DOWI : 43,870.35 (+1.06%)
DIA : 438.97 (+1.08%)
$IUXX : 20,740.78 (+0.36%)
QQQ : 504.98 (+0.36%)
ZNZ24 : 109-175 (-0.13%)
WBA : 8.30 (+0.73%)
UHS : 197.61 (+0.05%)
BILL : 89.98 (+2.41%)
FDX : 295.16 (+2.48%)
JBHT : 181.57 (-0.01%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy and ranks in the Top 1% of all short term signal directions.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Disc Medicine Inc. is a clinical-stage biopharmaceutical company. It focused on the discovery and development of novel treatments for patients suffering from serious hematologic diseases. Disc Medicine Inc., formerly known as Gemini Therapeutics Inc., is based in WAYLAND, Mass.

See More

Key Turning Points

3rd Resistance Point 67.38
2nd Resistance Point 65.04
1st Resistance Point 63.79
Last Price 63.51
1st Support Level 60.20
2nd Support Level 57.86
3rd Support Level 56.61

See More

52-Week High 77.60
Last Price 63.51
Fibonacci 61.8% 57.74
Fibonacci 50% 51.60
Fibonacci 38.2% 45.46
52-Week Low 25.60

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar